The University of Texas MD Anderson Cancer Center and Royal Philips are providing oncologists with evidence-based therapy and clinical trial guidance through Philips' oncology informatics solutions and MD Anderson's Precision Oncology Decision Support system.
Isoray Inc. has entered a research grant agreement with the University of Cincinnati Physicians Company for a study on treatment of recurrent head and neck cancers.
NCI, The Leukemia & Lymphoma Society and the Children's Oncology Group plan to develop a global precision medicine clinical trial for children with acute leukemia.
New recommendations from a large, multidisciplinary consensus conference published this week in the Journal of Clinical Oncology suggest expanding use of genetic testing to guide treatment for men with prostate cancer, including the use of panel testing and testing patients with early stage disease.
In a phase II clinical trial, patients with high-grade serous ovarian cancer who were treated with berzosertib and chemotherapy lived substantially longer than did those treated with chemotherapy alone.
The phase III IMpassion031 study, evaluating Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [albumin-bound paclitaxel, nab-paclitaxel]; followed by doxorubicin and cyclophosphamide) in comparison to placebo plus chemotherapy (including Abraxane), met its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in pathological complete response for the treatment of people with early triple-negative breast cancer, regardless of PD-L1 expression.
In the ACE-CL-001 trial, data showed 97% of previously untreated CLL patients continued to respond to treatment after more than four years with no new safety signals.
A method of analysing cancer patients' blood for evidence of the disease could be up to 10 times more sensitive than previous methods, according to research funded by Cancer Research UK and published in Science Translational Medicine.
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis received an “exceptional” rating from NCI during its site visit for 2020.
Charles L. Sawyers, chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, was elected president-elect by the fellows of the American Association for Cancer Research for 2020-2021.
